N95.2Dagger codeAsterisk codeF

Postmenopausal atrophic vaginitis

Menopausal and other perimenopausal disorders

Cited in 2 documents

GuidelinesHormone Therapy (HT)General measures Medicine treatment Referral N95.1-2/N95.8-9 Indications: Short-term symptomatic relief for severe menopausal symptoms. For menopausal women, treatment should be ≤ 5 years. Risk-benefit assessment should be individualised in all patients. Contra-indications include: Known or suspected estrogen-dependent malignant tumours (such as endometrial cancer). Coronary heart disease. Active
GuidelinesMenopause and Perimenopausal SyndromeReferral ICD-10 code: N95.0-3/N95.8-9 For primary management with hormone therapy (HT), refer to the PHC STGs and EML, Hormone therapy (HT) . If HT is contra-indicated, poorly tolerated or ineffective: Fluoxetine, oral Initiate at 20 mg on alternate days. If there is no response after 12 weeks, increase the dose to 20 mg daily. LoE:IIIb xxxix If on tamoxifen: Citalopram, oral, 10 mg d